Global Cell and Gene Therapy Manufacturing Services Market Research Report 2022(Status and Outlook)

Table of Contents

TABLE OF CONTENTS
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Manufacturing Services
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy Manufacturing Services Segment by Type
1.2.2 Cell and Gene Therapy Manufacturing Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cell and Gene Therapy Manufacturing Services Market Overview
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cell and Gene Therapy Manufacturing Services Market Competitive Landscape
3.1 Global Cell and Gene Therapy Manufacturing Services Sales by Manufacturers (2017-2022)
3.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Manufacturers (2017-2022)
3.3 Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell and Gene Therapy Manufacturing Services Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Cell and Gene Therapy Manufacturing Services Sales Sites, Area Served, Product Type
3.6 Cell and Gene Therapy Manufacturing Services Market Competitive Situation and Trends
3.6.1 Cell and Gene Therapy Manufacturing Services Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell and Gene Therapy Manufacturing Services Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cell and Gene Therapy Manufacturing Services Industry Chain Analysis
4.1 Cell and Gene Therapy Manufacturing Services Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cell and Gene Therapy Manufacturing Services Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cell and Gene Therapy Manufacturing Services Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Type (2017-2022)
6.3 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2017-2022)
6.4 Global Cell and Gene Therapy Manufacturing Services Price by Type (2017-2022)
7 Cell and Gene Therapy Manufacturing Services Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell and Gene Therapy Manufacturing Services Market Sales by Application (2017-2022)
7.3 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2017-2022)
7.4 Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2017-2022)
8 Cell and Gene Therapy Manufacturing Services Market Segmentation by Region
8.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
8.1.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
8.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region
8.2 North America
8.2.1 North America Cell and Gene Therapy Manufacturing Services Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell and Gene Therapy Manufacturing Services Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell and Gene Therapy Manufacturing Services Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell and Gene Therapy Manufacturing Services Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Basic Information
9.1.2 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Overview
9.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Market Performance
9.1.4 Thermo Fisher Scientific Business Overview
9.1.5 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services SWOT Analysis
9.1.6 Thermo Fisher Scientific Recent Developments
9.2 Merck KGaA
9.2.1 Merck KGaA Cell and Gene Therapy Manufacturing Services Basic Information
9.2.2 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Overview
9.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Market Performance
9.2.4 Merck KGaA Business Overview
9.2.5 Merck KGaA Cell and Gene Therapy Manufacturing Services SWOT Analysis
9.2.6 Merck KGaA Recent Developments
9.3 Charles River Laboratories
9.3.1 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Basic Information
9.3.2 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Overview
9.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Market Performance
9.3.4 Charles River Laboratories Business Overview
9.3.5 Charles River Laboratories Cell and Gene Therapy Manufacturing Services SWOT Analysis
9.3.6 Charles River Laboratories Recent Developments
9.4 Lonza
9.4.1 Lonza Cell and Gene Therapy Manufacturing Services Basic Information
9.4.2 Lonza Cell and Gene Therapy Manufacturing Services Product Overview
9.4.3 Lonza Cell and Gene Therapy Manufacturing Services Product Market Performance
9.4.4 Lonza Business Overview
9.4.5 Lonza Cell and Gene Therapy Manufacturing Services SWOT Analysis
9.4.6 Lonza Recent Developments
9.5 Catalent
9.5.1 Catalent Cell and Gene Therapy Manufacturing Services Basic Information
9.5.2 Catalent Cell and Gene Therapy Manufacturing Services Product Overview
9.5.3 Catalent Cell and Gene Therapy Manufacturing Services Product Market Performance
9.5.4 Catalent Business Overview
9.5.5 Catalent Cell and Gene Therapy Manufacturing Services SWOT Analysis
9.5.6 Catalent Recent Developments
9.6 WuXi AppTec
9.6.1 WuXi AppTec Cell and Gene Therapy Manufacturing Services Basic Information
9.6.2 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Overview
9.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Market Performance
9.6.4 WuXi AppTec Business Overview
9.6.5 WuXi AppTec Recent Developments
9.7 Takara Bio Inc
9.7.1 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Basic Information
9.7.2 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Overview
9.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Market Performance
9.7.4 Takara Bio Inc Business Overview
9.7.5 Takara Bio Inc Recent Developments
9.8 Nikon Corporation
9.8.1 Nikon Corporation Cell and Gene Therapy Manufacturing Services Basic Information
9.8.2 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Overview
9.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
9.8.4 Nikon Corporation Business Overview
9.8.5 Nikon Corporation Recent Developments
9.9 FUJIFILM Holdings Corporation
9.9.1 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Basic Information
9.9.2 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Overview
9.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
9.9.4 FUJIFILM Holdings Corporation Business Overview
9.9.5 FUJIFILM Holdings Corporation Recent Developments
9.10 F. Hoffmann-La Roche
9.10.1 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Basic Information
9.10.2 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Overview
9.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Market Performance
9.10.4 F. Hoffmann-La Roche Business Overview
9.10.5 F. Hoffmann-La Roche Recent Developments
9.11 Oxford Biomedica Plc
9.11.1 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Basic Information
9.11.2 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Overview
9.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Market Performance
9.11.4 Oxford Biomedica Plc Business Overview
9.11.5 Oxford Biomedica Plc Recent Developments
9.12 Cell and Gene Therapy Catapult
9.12.1 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Basic Information
9.12.2 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Overview
9.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Market Performance
9.12.4 Cell and Gene Therapy Catapult Business Overview
9.12.5 Cell and Gene Therapy Catapult Recent Developments
9.13 The Discovery Labs LLC
9.13.1 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Basic Information
9.13.2 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Overview
9.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Market Performance
9.13.4 The Discovery Labs LLC Business Overview
9.13.5 The Discovery Labs LLC Recent Developments
9.14 RoslinCT
9.14.1 RoslinCT Cell and Gene Therapy Manufacturing Services Basic Information
9.14.2 RoslinCT Cell and Gene Therapy Manufacturing Services Product Overview
9.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Product Market Performance
9.14.4 RoslinCT Business Overview
9.14.5 RoslinCT Recent Developments
9.15 JRS PHARMA
9.15.1 JRS PHARMA Cell and Gene Therapy Manufacturing Services Basic Information
9.15.2 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Overview
9.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Market Performance
9.15.4 JRS PHARMA Business Overview
9.15.5 JRS PHARMA Recent Developments
9.16 FinVector
9.16.1 FinVector Cell and Gene Therapy Manufacturing Services Basic Information
9.16.2 FinVector Cell and Gene Therapy Manufacturing Services Product Overview
9.16.3 FinVector Cell and Gene Therapy Manufacturing Services Product Market Performance
9.16.4 FinVector Business Overview
9.16.5 FinVector Recent Developments
9.17 ABL
9.17.1 ABL Cell and Gene Therapy Manufacturing Services Basic Information
9.17.2 ABL Cell and Gene Therapy Manufacturing Services Product Overview
9.17.3 ABL Cell and Gene Therapy Manufacturing Services Product Market Performance
9.17.4 ABL Business Overview
9.17.5 ABL Recent Developments
9.18 Resilience
9.18.1 Resilience Cell and Gene Therapy Manufacturing Services Basic Information
9.18.2 Resilience Cell and Gene Therapy Manufacturing Services Product Overview
9.18.3 Resilience Cell and Gene Therapy Manufacturing Services Product Market Performance
9.18.4 Resilience Business Overview
9.18.5 Resilience Recent Developments
9.19 BioCentriq
9.19.1 BioCentriq Cell and Gene Therapy Manufacturing Services Basic Information
9.19.2 BioCentriq Cell and Gene Therapy Manufacturing Services Product Overview
9.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Product Market Performance
9.19.4 BioCentriq Business Overview
9.19.5 BioCentriq Recent Developments
9.20 Porton Biopharma Limited
9.20.1 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Basic Information
9.20.2 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Overview
9.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Market Performance
9.20.4 Porton Biopharma Limited Business Overview
9.20.5 Porton Biopharma Limited Recent Developments
9.21 Andelyn Biosciences
9.21.1 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Basic Information
9.21.2 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Overview
9.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Market Performance
9.21.4 Andelyn Biosciences Business Overview
9.21.5 Andelyn Biosciences Recent Developments
9.22 Commercializing Living Therapies
9.22.1 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Basic Information
9.22.2 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Overview
9.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Market Performance
9.22.4 Commercializing Living Therapies Business Overview
9.22.5 Commercializing Living Therapies Recent Developments
9.23 Vibalogics
9.23.1 Vibalogics Cell and Gene Therapy Manufacturing Services Basic Information
9.23.2 Vibalogics Cell and Gene Therapy Manufacturing Services Product Overview
9.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Product Market Performance
9.23.4 Vibalogics Business Overview
9.23.5 Vibalogics Recent Developments
9.24 Anemocyte Srl
9.24.1 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Basic Information
9.24.2 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Overview
9.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Market Performance
9.24.4 Anemocyte Srl Business Overview
9.24.5 Anemocyte Srl Recent Developments
9.25 ElevateBio
9.25.1 ElevateBio Cell and Gene Therapy Manufacturing Services Basic Information
9.25.2 ElevateBio Cell and Gene Therapy Manufacturing Services Product Overview
9.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Product Market Performance
9.25.4 ElevateBio Business Overview
9.25.5 ElevateBio Recent Developments
10 Cell and Gene Therapy Manufacturing Services Market Forecast by Region
10.1 Global Cell and Gene Therapy Manufacturing Services Market Size Forecast
10.2 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country
10.2.3 Asia Pacific Cell and Gene Therapy Manufacturing Services Market Size Forecast by Region
10.2.4 South America Cell and Gene Therapy Manufacturing Services Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell and Gene Therapy Manufacturing Services by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Cell and Gene Therapy Manufacturing Services by Type (2022-2028)
11.1.2 Global Cell and Gene Therapy Manufacturing Services Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Cell and Gene Therapy Manufacturing Services by Type (2022-2028)
11.2 Global Cell and Gene Therapy Manufacturing Services Market Forecast by Application (2022-2028)
11.2.1 Global Cell and Gene Therapy Manufacturing Services Sales (K Units) Forecast by Application
11.2.2 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings